The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients Frederik A. VerburgMarkus Lusterfor the EANM Thyroid, Radiation Protection and Dosimetry Committees Editorial 16 February 2017 Pages: 915 - 917
Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option Jérôme ClercFrederik A. VerburgDavid Taïeb Editorial 17 February 2017 Pages: 918 - 925
Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy Arnoldo PiccardoMatteo PuntoniLuca Giovanella Original Article 14 December 2016 Pages: 926 - 934
Measuring the actual I-131 thyroid uptake curve with a collar detector system: a feasibility study Peter BrinksKoen Van GilsJan B. A. Habraken Original Article 17 December 2016 Pages: 935 - 940
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour Christian UprimnyAlexander Stephan KroissIrene Johanna Virgolini Original Article 31 January 2017 Pages: 941 - 949
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095 Ali Afshar-OromiehUwe HaberkornClemens Kratochwil Original Article Open access 09 March 2017 Pages: 950 - 959
Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer Sebastian SchmuckStefan NordlohneThorsten Derlin Original Article 09 March 2017 Pages: 960 - 968
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers Satoshi TakeuchiEric M. RohrenAhmed O. Kaseb Original Article 12 December 2016 Pages: 969 - 978
Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas Céline HeimburgerFrancis VeillonAlessio Imperiale Original Article 03 January 2017 Pages: 979 - 987
Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation Musaddiq J. AwanPierre LavertuMin Yao Original Article 14 January 2017 Pages: 988 - 997
The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer Inne J. den ToomAnnelies van SchieRemco de Bree Original Article Open access 29 January 2017 Pages: 998 - 1004
18F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed? Julian KirchnerCornelius DeuschlLale Umutlu Original Article 04 February 2017 Pages: 1005 - 1013
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 Wolfgang P. FendlerMatthias EiberKen Herrmann Guidelines 10 March 2017 Pages: 1014 - 1024
Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging Simon KallerMichael RullmannOsama Sabri Original Article 14 February 2017 Pages: 1025 - 1032
Neural correlates of the popular music phenomenon: evidence from functional MRI and PET imaging Qiaozhen ChenYing ZhangMei Tian Original Article 12 January 2017 Pages: 1033 - 1041
PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans Ansel T. HillmerSongye LiYiyun Huang Original Article 24 January 2017 Pages: 1042 - 1050
Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study Raphaëlle RichieriDamien JouvenozEric Guedj Original Article 03 February 2017 Pages: 1051 - 1055
Central noradrenaline transporter availability in highly obese, non-depressed individuals Swen HesseGeorg-Alexander BeckerOsama Sabri Original Article 09 January 2017 Pages: 1056 - 1064
Imaging the DNA damage response with PET and SPECT James C. KnightSofia KoustoulidouBart Cornelissen Review Article Open access 05 January 2017 Pages: 1065 - 1078
An update on the role of PET/CT and PET/MRI in ovarian cancer Benjapa KhiewvanDrew A. TorigianAbass Alavi Review Article 08 February 2017 Pages: 1079 - 1091
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials? Sandip BasuAshwini Kalshetty Letter to the Editor 24 February 2017 Pages: 1092 - 1094
Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging Paolo Zanotti-FregonaraClément MorgatElif Hindié Letter to the Editor 10 March 2017 Pages: 1095 - 1096
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma Constantin LapaAndreas SchirbelMartin Schreder Image of the Month 25 February 2017 Pages: 1097 - 1098
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer Mike SathekgeOtto KnoesenSebastian Marx Image of the Month Open access 02 March 2017 Pages: 1099 - 1100
Juliano Cerci, Stefano Fanti, Dominique Delbeke (Eds): Oncological PET/CT with Histological Confirmation Valentina PiscopoLuigi Mansi Book Review 24 January 2017 Pages: 1101 - 1101
Atlas of Anatomy - Third Edition. Anne M. Gilroy and Brian R. MacPherson (Eds) On the basis of the work of Michael Schuenke, Erik Schulte and Udo Schumaker Gennaro MellusoLuigi Mansi Book Review 21 January 2017 Pages: 1102 - 1103
In memoriam Professor Jan van der Schoot (1927–2017) Ellinor Busemann SokoleRenato Valdés Olmos Obituary 03 March 2017 Pages: 1104 - 1105
